XML 104 R46.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholder Equity (Details Narrative) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Nov. 18, 2024
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Oct. 30, 2020
Weighted-average period     3 years    
Unrecognized compensation expense     $ 2,162,398    
Granted   3,549,292      
Preferred stock shares authorized     50,000,000 50,000,000  
Common stock shares authorized     200,000,000 200,000,000  
Preferred stock, shares designated         1,000,000
Warrants outstanding   3,549,292   0  
Preferred stock, par value     $ 0.0001 $ 0.0001 $ 0.0001
Common stock, par value     $ 0.0001 $ 0.0001  
Common stock, shares issue     144,301,977 132,667,107  
Common stock, shares outstanding     144,301,977 132,667,107  
Consultant [Member]          
Stock-based Compensation     $ 907,225 $ 925,181  
Stock Option [Member]          
Stock-based Compensation     $ 0 $ 50,000  
Stock options issued     9,668,116    
Reserved options remaining for issuance     14,331,884    
Average grant-date fair value     $ 0.46    
Number of option include performance conditions     3,399,646    
Stock Option [Member] | Vest Upon Achievement Of 50% Target [Member]          
Vested percentage     50.00%    
Stock Option [Member] | Vest Upon Achievement Of 50% Revenue Target [Member]          
Vested percentage     50.00%    
Revenue Target     $ 100,000,000    
Achive revenue target     15,000,000    
Annual revenue achive for fiscal year 2026     20,000,000    
Restricted Stock Units [Member]          
Unrecognized compensation expense     $ 2,330,508    
Chief Executive Officer [Member]          
Options granted     2,250,000    
Chief Operating Officer [Member]          
Options granted     231,000    
key employee [Member]          
Options granted     1,068,292    
Board of Directors and Executive Team [Member]          
Amount particiated in offering $ 696,000   $ 673    
Shares recevied in offering 556,800        
Warrant received 835,200        
Warrants [Member]          
Dividend Yield     0.00%    
Expected Life     5 years    
Granted     14,675,244    
Expected Volatility     24.80%    
Risk-free Interest Rate     4.28%    
Warrants outstanding       1,235,000  
Restricted Stock Member | Director [Member]          
Common stock issued for services     301,209 20,000  
Fair value of common share     $ 383,879 $ 71,200  
Restricted Stock Member | Former employees [Member]          
Common stock issued for services     1,499,655    
Fair value of common share     $ 60,000    
Restricted Stock Units RSU Member          
Unrecognized compensation expense     $ 1,709,608    
Granted     3,549,292    
unvested restricted stock units     1,649,646    
Performance based restricted stock units     1,899,646    
Vesting restricted stock units recognized period     3 years 4 months 28 days    
Performance-based vesting conditions for restricted stock units     The performance-based units vest as follows: 50% vest upon the achievement of Operating Profit, as defined in the employment agreements, and 50% upon the achievement of revenue targets between $15.0 million and $100 million by the end of fiscal year 2028. The restricted stock units with the revenue target begin vesting once the Company achieves $15.0 million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of restricted stock units that vest is based on the proportionate percentage of each fiscal year’s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20 million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027    
Stock-based Compensation     $ 308,399    
Service Based Options [Member]          
Weighted-average period     2 years 10 months 9 days    
Unrecognized compensation expense     $ 2,162,398    
Performance Based Option [Member]          
Unrecognized compensation expense     1,571,405    
General and administrative [Member]          
Stock-based Compensation     738,147 796,881  
Research and development [Member]          
Stock-based Compensation     $ 169,078 $ 128,300  
Private Placement Offering [Member]          
Common stock warrants issued     14,675,244    
Warrants outstanding     1,235,000 15,000  
Exercise price     $ 2.50    
Common stock share issued     15,000    
Gross proceeds     $ 37,500    
Market price     $ 0.68    
Equity Distribution Agreement [Member]          
Sale of common stock shares     50,510 3,766,422  
Net proceeds     $ 0 $ 13,441,438  
Gross process from private placement of stocks     62,400    
Commission fees     2,400 230,000  
Legal fees     63,100 $ 110,000  
Net equity issuance costs     $ 3,100    
Open market sale agreement [Member]          
Sale of common stock shares     3,816,932    
Remaining number of share for market public facility     86,154,000    
Equity Incentive Plan 2021 [Member]          
Common stock issued for services     24,000,000    
Common stock, shares issue     10,000,000    
2021 Plan [Member]          
Options exercised     1,446,901 2,283,800  
Issuance of common shares     999,655 2,067,902  
Exercise of common stock     $ 500,000 $ 95,238  
Exercise price     $ 0.12 $ 1.05  
Options granted     6,700,000    
Options granted to settle legal matter     5,900,000    
Common stock share issued     500,000 95,238  
Gross proceeds     $ 60,000 $ 100,000  
Securities Purchase Agreement [Member]          
Net proceeds $ 11,393,000        
Fair values of warrant     $ 8,118,000 $ 3,275,000  
Legal fees 357,000        
Agent fees 481,000        
Share issued and sell description     The purchase price for one share and the accompanying 1.5 warrants was $1.25. The warrants are immediately exercisable for a period of five years from the date of the Offering at $1.125, subject to adjustment in the event of any stock dividends and splits, reverse stock split, recapitalization, reorganization, or similar transactions and include anti-dilution protection provisions in the event subsequent sales or equity-linked financial instruments are issued at a price below the $1.125    
Common stock share issued     9,783,496    
Warrants to purchase     14,675,244    
Gross proceeds $ 12,229,000        
Bottom [Member] | Restricted Stock Units [Member]          
Grant-date fair value of the restricted stock     $ 1.03    
Top [Member] | Restricted Stock Units [Member]          
Grant-date fair value of the restricted stock     $ 1.30